Cargando…

The OM-85 bacterial lysate: a new tool against SARS-CoV-2?

The emergence of SARS-CoV-2, a novel coronavirus, caused the global Coronavirus disease of 2019 (COVID-19) pandemic. Because SARS-CoV-2 mutates rapidly, vaccines that induce immune responses against viral components critical for target cell infection strongly mitigate but do not abrogate viral sprea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivniouk, Vadim, Vercelli, Donata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PAGEPress Publications, Pavia, Italy 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926922/ https://www.ncbi.nlm.nih.gov/pubmed/36798954 http://dx.doi.org/10.4081/mrm.2023.906

Ejemplares similares

The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression
por: Pivniouk, Vadim, et al.
Publicado: (2022)

OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells
por: Fang, Lei, et al.
Publicado: (2021)

Airway Administration of Bacterial Lysate OM-85 Protects Mice Against Respiratory Syncytial Virus Infection
por: Antunes, Krist Helen, et al.
Publicado: (2022)

Use of the Bacterial Lysate OM-85 in the Paediatric Population in Italy: A Retrospective Cohort Study
por: Cantarutti, Anna, et al.
Publicado: (2021)

Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study
por: Bodemer, Christine, et al.
Publicado: (2017)

Bacterial lysates (OM-85 BV): a cost-effective proposal in order to contrast antibiotic resistance
por: TROIANO, GIANMARCO, et al.
Publicado: (2021)

Prevention of respiratory tract infections with bacterial lysate OM-85 bronchomunal in children and adults: a state of the art
por: De Benedetto, Fernando, et al.
Publicado: (2013)

Microbiota profiles in pre-school children with respiratory infections: Modifications induced by the oral bacterial lysate OM-85
por: Esposito, Susanna, et al.
Publicado: (2022)

Can bacterial lysates be useful in prevention of viral respiratory infections in childhood? The results of experimental OM-85 studies
por: Ballarini, Stefania, et al.
Publicado: (2022)

Clinical and Immunological Benefits of OM-85 Bacterial Lysate in Patients with Allergic Rhinitis, Asthma, and COPD and Recurrent Respiratory Infections
por: Koatz, Ana M., et al.
Publicado: (2016)

Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response
por: Baladi, S., et al.
Publicado: (1994)

The SARS-CoV-2 Entry Inhibition Mechanisms of Serine Protease Inhibitors, OM-85, Heparin and Soluble HS Might Be Linked to HS Attachment Sites
por: Cheudjeu, Antony
Publicado: (2022)

OM-85 is an immunomodulator of interferon-β production and inflammasome activity
por: Dang, A. T., et al.
Publicado: (2017)

P.85 Severe SARS-CoV-2 in pregnancy
por: Watson, S., et al.
Publicado: (2022)

Sars-CoV-2 échappé d’un laboratoire chinois ? L’OMS laisse tomber
por: Manus, Jean-Marie
Publicado: (2023)

L’OMS sur la trace vers le réservoir animal du Sars-CoV-2
por: Manus, Jean-Marie
Publicado: (2021)

Effect of OM-85 BV on reducing bronchiectasis exacerbation in Chinese patients: the iPROBE study
por: Gao, Jinming, et al.
Publicado: (2021)

Expert consensus on the role of OM-85 in the management of recurrent respiratory infections: A Delphi study
por: Esposito, Susanna, et al.
Publicado: (2022)

OM-85 BV in pediatric recurrent respiratory tract infections: a cost-utility analysis
por: Buendía, Jefferson Antonio, et al.
Publicado: (2022)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

Evidence that a primary anti-viral stimulation of the immune response by OM-85 reduces susceptibility to a secondary respiratory bacterial infection in mice
por: Rossi, Giovanni A., et al.
Publicado: (2018)

Viral Related Tools against SARS-CoV-2
por: Fernandez-Garcia, Laura, et al.
Publicado: (2020)

Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM‐85
por: Lauzon‐Joset, Jean‐Francois, et al.
Publicado: (2021)

Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany
por: Michelitsch, Anna, et al.
Publicado: (2020)

Investigating the Prevalence and Risk Factors Associated With SARS-CoV-2 Infection Among Oral & Maxillofacial (OMS) Residents in the United States
por: Thomas, Marvin, et al.
Publicado: (2021)

IRF7-Associated Immunophenotypes Have Dichotomous Responses to Virus/Allergen Coexposure and OM-85-Induced Reprogramming
por: de Jong, Emma, et al.
Publicado: (2021)

Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products
por: Klein, Günter, et al.
Publicado: (2013)

Profiling the B cell immune response elicited by vaccination against the respiratory virus SARS-CoV-2
por: Pettini, Elena, et al.
Publicado: (2022)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Selective Activation of Human Dendritic Cells by OM-85 through a NF-kB and MAPK Dependent Pathway
por: Parola, Carmen, et al.
Publicado: (2013)

SARS-CoV-2 Lysate Stimulation Impairs the Release of Platelet-like Particles and Megakaryopoiesis in the MEG-01 Cell Line
por: Lopardo, Valentina, et al.
Publicado: (2023)

Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador
por: Salinas, Marco, et al.
Publicado: (2022)

Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)
por: Sessa, Francesco, et al.
Publicado: (2021)

Devil's tools: SARS-CoV-2 antagonists against innate immunity
por: Xu, Duo, et al.
Publicado: (2021)

Molecular Diagnostic Tools against SARS-CoV-2 in Poland in 2022
por: Fulawka, Lukasz, et al.
Publicado: (2022)

Experimental Infection of Cattle with SARS-CoV-2
por: Ulrich, Lorenz, et al.
Publicado: (2020)

P85 Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic
Publicado: (2021)

In response to: "Diagnostic evaluation of nCoV-QS, nCoV-QM-N, and nCoV-OM detection kits based on rRT-PCR for detection of SARS-CoV-2 in Ecuador"
por: Garcia-Bereguiain, Miguel Angel
Publicado: (2023)

Development and validation of the CoV19-OM intensive care unit score: An early ICU identification for laboratory-confirmed SARS-CoV-2 patients from a retrospective cohort study in Oman
por: Lacap, Eduardo M., et al.
Publicado: (2022)

To investigate the prevention of OM-85 on bronchiectasis exacerbations (iPROBE) in Chinese patients: study protocol for a randomized controlled trial
por: Gao, Jinming, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8717tcnq7ri91g4s8ruilvr8q6